GUIDED THERAPEUTICS INC (247) | Uncategorized (143)
Recent Contracts
-
Form of Warrants issued to Auctus Fund, LLC
(Filed With SEC on September 15, 2022)
-
Form of Warrants issued to Auctus Fund, LLC
(Filed With SEC on September 15, 2022)
-
Agreement dated September 30, 2021, by and between Guided Therapeutics, Inc. and Richard P. Blumberg
(Filed With SEC on March 30, 2022)
-
Amendment to the Agreement by and between Guided Therapeutics Inc. and Shandong Yaohua Medical Instrument Corporation, dated August 12, 2021
(Filed With SEC on September 7, 2021)
-
Form of Acknowledgement
(Filed With SEC on June 10, 2021)
-
Finders Fee Agreement with JH Darbie, dated as of May 19, 2020
(Filed With SEC on April 7, 2021)
-
Finders Fee Agreement with FCMI, dated as of June 11, 2020
(Filed With SEC on April 7, 2021)
-
Finders Fee Agreement, dated as of January 6, 2020, by and between Guided Therapeutics, Inc. and Iron Stone Capital
(Filed With SEC on April 20, 2020)
-
Form of Exchange Agreement
(Filed With SEC on September 6, 2018)
-
Equity Financing Agreement dated March 1, 2018 by and between the Company and GHS Investments LLC
(Filed With SEC on June 14, 2018)
-
Form of Registration Rights Agreement dated March 8, 2018 by and between the Company and GHS Investments LLC
(Filed With SEC on June 14, 2018)
-
CONVERTIBLE PROMISSORY NOTE
(Filed With SEC on November 13, 2017)
-
SECURITIES PURCHASE AGREEMENT
(Filed With SEC on November 13, 2017)
-
SECURITIES PURCHASE AGREEMENT
(Filed With SEC on October 25, 2017)
-
SECURITIES PURCHASE AGREEMENT
(Filed With SEC on October 25, 2017)
-
CONVERTIBLE PROMISSORYNOTE
(Filed With SEC on August 24, 2017)
-
SECURITIES PURCHASE AGREEMENT
(Filed With SEC on August 24, 2017)
-
Forbearance Agreement, dated August 8, 2017, between the Company and GPB Debt Holdings II LLC
(Filed With SEC on August 17, 2017)
-
UNITED STATES SECURITIES AND EXCHANGECOMMISSION Washington, D.C.20549 FORM 8-K CURRENTREPORT Pursuant toSection 13 or 15(d) of the Securities ExchangeAct of 1934 Date of...
(Filed With SEC on August 14, 2017)
-
COMMON STOCK PURCHASE WARRANT Guided Therapeutics, Inc.
(Filed With SEC on June 7, 2017)
-
SECURITIES PURCHASE AGREEMENT
(Filed With SEC on June 7, 2017)
-
PLACEMENT AGENCY AGREEMENT June __, 2017
(Filed With SEC on June 7, 2017)
-
GUIDEDTHERAPEUTICS, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEMAY 17, 2018
(Filed With SEC on May 24, 2017)
-
GUIDEDTHERAPEUTICS, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEMAY 17, 2018 BACKEND NOTE
(Filed With SEC on May 24, 2017)
-
GUIDEDTHERAPEUTICS, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEMAY 17, 2018
(Filed With SEC on May 24, 2017)
-
GUIDEDTHERAPEUTICS, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEMAY 17, 2018 BACKEND NOTE
(Filed With SEC on May 24, 2017)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on May 24, 2017)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on May 24, 2017)
-
ADARBAYS, LLC COLLATERALIZEDSECURED PROMISSORY NOTE
(Filed With SEC on May 24, 2017)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on May 24, 2017)
-
[remainderof page intentionally left blank]
(Filed With SEC on March 30, 2017)
-
Agreement, dated January 22, 2017, between the Company and Shandong Yaohua Medical Instrument Corporation
(Filed With SEC on March 24, 2017)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on February 17, 2017)
-
COMMONSTOCK PURCHASE WARRANT GUIDEDTHERAPEUTICS, INC.
(Filed With SEC on February 17, 2017)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on February 17, 2017)
-
Agreement, dated January 22, 2017, between the Company and Shandong Yaohua Medical Instrument Corporation
(Filed With SEC on January 26, 2017)
-
Agreement, dated January 22, 2017, between the Company and Shenghuo Medical, LLC
(Filed With SEC on January 26, 2017)
-
10% OID Convertible Promissory Note
(Filed With SEC on December 30, 2016)
-
Securities Purchase Agreement, dated December 28, 2016, between the Company and RedDiamond
(Filed With SEC on December 30, 2016)
-
FORM OF NOTE
(Filed With SEC on December 7, 2016)